Loading... Please wait.
Company profile
CARMAT specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency who are ineligible for a transplant and have exhausted all medication alternatives.
Source:
Cofisem
-
Last Update:
04 Nov 2024
Key Executives
| Chief Executive Officer | Stéphane Piat | ||||
| Administrative & Finance Director | Pascale Arbonneau | ||||
| Head of Investor Relations | Pascale Arbonneau | ||||
| Chief Human Resources Officer | Raouia Bouyanzer | ||||
| Director Research & Development | Marc Grimmé | ||||
| Source: Cofisem - Last Update: 04 Nov 2024 | |||||
Key figures
| Millenium | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Net sales | 2.797 | 345 | 2.229 | 0 | 0 |
| Consumed purchases | 33.819 | 28.819 | 42.847 | 24.399 | 28.299 |
| Labour costs | 21.630 | 20.900 | 17.759 | 15.017 | 12.819 |
| Operating profit | -52.519 | -51.922 | -60.408 | -36.411 | -42.394 |
| Income tax | -1.698 | -2.062 | -1.863 | -1.711 | -1.636 |
| Net income | -53.869 | -53.681 | -61.873 | -36.963 | -42.649 |
| Fiscal year end | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | French_GAAP | French_GAAP | French_GAAP | French_GAAP | French_GAAP |
| Source: Cofisem - Last Update: 04 Nov 2024 | |||||
Shareholder information
Address
CARMAT
Immeuble l'Etendard 36 Avenue de l'Europe
FR-78140
Vélizy-Villacoublay
France
Phone number:
+33 (0)1 39 45 64 50
Fax:
+33 (0)1 39 45 64 51
Source:
Cofisem
-
Last Update:
04 Nov 2024